Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department

Withdrawn before enrolling · Not applicable

Conditions studied: Anaphylaxis

In brief

To determine if intravenous unfractionated heparin (with standard therapy) for treatment of anaphylaxis results in faster time to recovery.

Key facts

Study ID

NCT00657228

Run by

University of Missouri, Kansas City

People needed

0

Starts

2009-12-01

Expected to finish

2010-12-01

Last updated by the study team

2017-01-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years and older
• English speaking
• Meets one of the above definitions of anaphylaxis
• Signs/symptoms onset <12 hours will get epinephrine or will not get epinephrine because of contraindication to epinephrine administration.

You may not qualify if…

• History of Intracranial Hemorrhage at anytime
• Known Cerebral Vascular Lesion (i.e. Aneurysm, Arteriovenous malformation)
• Ischemic CVA within the last 3 months
• Suspected Aortic Dissection
• Active Bleeding
• Known Bleeding/Clotting Disorder
• Closed Head Trauma within the past 3 months
• Major Surgery (Abdominal/Thoracic) within the last 3 weeks
• Active GI Bleeding
• Currently taking Warfarin
• Allergy to Heparins
• History of Heparin-induced Thrombocytopenia (AHA contraindications to fibrinolytic therapy 2005, Micromedix 2007)

Where it is running

• Truman Medical Center ED — Kansas City, Missouri, United States
• St. Luke's Hospital ED — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.